These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1797535)
1. Conversion from cyclosporin to azathioprine in renal allograft recipients. Otieno LS; Kinuthia DM; McLigeyo SO; Orinda DA; Mwongera FK East Afr Med J; 1991 Sep; 68(9):720-6. PubMed ID: 1797535 [TBL] [Abstract][Full Text] [Related]
2. Long-term benefits and risks of cyclosporin A (sandimmun)--an analysis at 10 years. Thiel G; Bock A; Spöndlin M; Brunner FP; Mihatsch M; Rufli T; Landmann J Transplant Proc; 1994 Oct; 26(5):2493-8. PubMed ID: 7940765 [TBL] [Abstract][Full Text] [Related]
3. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients. Hricik DE; Seliga RM; Fleming-Brooks S; Bartucci MR; Schulak JA Clin Transplant; 1995 Oct; 9(5):419-23. PubMed ID: 8541637 [TBL] [Abstract][Full Text] [Related]
4. [The effect of cyclosporin on renal function following cardiac transplantation: should one lessen the toxicity?]. Carrier M; Pelletier GB; Leclerc Y; Castonguay YR; Solymoss BC; Pelletier LC Can J Surg; 1990 Jun; 33(3):243-7. PubMed ID: 2350751 [TBL] [Abstract][Full Text] [Related]
5. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results. Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555 [TBL] [Abstract][Full Text] [Related]
6. Conversion of cyclosporine A to tacrolimus following heart transplantation. Mathieu P; Carrier M; White M; Pellerin M; Perrault LP; Pelletier G; Pelletier LC Can J Cardiol; 1999 Nov; 15(11):1229-32. PubMed ID: 10579737 [TBL] [Abstract][Full Text] [Related]
7. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy. Crowson MC; Berisa F; McGonigle RJ; Adu D; Michael J; Barnes AD Nephrol Dial Transplant; 1989; 4(2):129-32. PubMed ID: 2496354 [TBL] [Abstract][Full Text] [Related]
8. Long-term graft survival after conversion from cyclosporin to azathioprine 1 year after renal transplantation. A prospective, randomized study from 1 to 6 years after transplantation. Pedersen EB; Hansen HE; Kornerup HJ; Madsen S; Sørensen AW Nephrol Dial Transplant; 1993; 8(3):250-4. PubMed ID: 8385294 [TBL] [Abstract][Full Text] [Related]
9. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months. Aichberger C; Eberl T; Riedmann B; Pernthaler H; Ofner D; Königsrainer A; Margreiter R Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521 [TBL] [Abstract][Full Text] [Related]
10. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients. Paydaş S; Balal M; Sertdemir Y; Seyrek N; Karayaylali I Ren Fail; 2005; 27(4):409-13. PubMed ID: 16060128 [TBL] [Abstract][Full Text] [Related]
11. Cyclosporine as primary therapy for A-matched living related donor kidney graft recipients. MacDonald AS; Belitsky P; Bitter-Suermann H; Cohen A Transplant Proc; 1989 Feb; 21(1 Pt 2):1667-9. PubMed ID: 2652546 [TBL] [Abstract][Full Text] [Related]
12. Renal allograft immunosuppression. II. A randomized trial of withdrawal of one drug in triple drug immunosuppression. Isoniemi H; Ahonen J; Eklund B; Höckerstedt K; Salmela K; von Willebrand E; Häyry P Transpl Int; 1990 Oct; 3(3):121-7. PubMed ID: 2271083 [TBL] [Abstract][Full Text] [Related]
13. Conversion from cyclosporin to azathioprine 3 months after renal transplantation--is it safe? Cassidy MJ; Irving E; Swanepoel CR; Pascoe MD; van Zyl-Smit R; Jacobson JE S Afr Med J; 1986 Sep; 70(6):317-8. PubMed ID: 3529454 [TBL] [Abstract][Full Text] [Related]
14. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection. Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267 [TBL] [Abstract][Full Text] [Related]
16. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309 [TBL] [Abstract][Full Text] [Related]
17. Long-term renal function in heart transplant recipients receiving cyclosporine therapy. Goral S; Ynares C; Shyr Y; Yeoh TK; Johnson HK J Heart Lung Transplant; 1997 Nov; 16(11):1106-12. PubMed ID: 9402509 [TBL] [Abstract][Full Text] [Related]
18. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients. Grimbert P; Baron C; Fruchaud G; Hemery F; Desvaux D; Buisson C; Chopin D; Dahmane D; Remy P; Pastural M; Abbou C; Weil B; Lang P Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659 [TBL] [Abstract][Full Text] [Related]